Sanofi - Common Stock and American Depositary Receipts (SNY)

Historical Holders from Q1 2014 to Q4 2025

Type / Class
Equity / Common Stock and American Depositary Receipts
Symbol
SNY on Nasdaq
Shares outstanding
1,226,467,754
Price per share
$48.46
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares as of 30 Sep 2025
237,646,783
Total reported value
$11,217,952,523
% of total 13F portfolios
0.01%
Share change
-11,197,291
Value change
-$540,304,609
Avg buy value change
+0%
Avg sell value change
-0%
Number of holders
695
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Sanofi - Common Stock and American Depositary Receipts (SNY) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Amundi 5.2% +3.6% $3,016,031,384 +$100,496,682 63,898,970 +3.4% AMUNDI 30 Sep 2025
As of 30 Sep 2025, Sanofi - Common Stock and American Depositary Receipts (SNY) has 695 institutional shareholders filing 13F forms. They hold 237,646,783 shares. of 1,226,467,754 outstanding shares (19%) .

Top 25 institutional shareholders own 14% of the company.

Filer Ownership Nb Shares Share Change % Portfolio % Holdings Value
Dodge & Cox 5.6% 68,931,747 -3.9% 1.8% $3,253,578,458
Fisher Asset Management, LLC 1% 12,578,746 -4.2% 0.21% $593,716,853
BANK OF AMERICA CORP /DE/ 0.8% 9,872,475 -1.3% 0.03% $465,980,810
MORGAN STANLEY 0.62% 7,561,925 -8.4% 0.02% $356,922,960
BARROW HANLEY MEWHINNEY & STRAUSS LLC 0.58% 7,126,993 -2.1% 1.1% $336,394,070
PRICE T ROWE ASSOCIATES INC /MD/ 0.48% 5,873,539 +6.3% 0.03% $277,233,000
Invesco Ltd. 0.47% 5,797,547 -37% 0.04% $273,644,210
BlackRock, Inc. 0.45% 5,578,736 +2% 0% $263,316,311
WELLINGTON MANAGEMENT GROUP LLP 0.34% 4,123,755 -4.8% 0.03% $194,641,236
FRANKLIN RESOURCES INC 0.32% 3,931,758 -8% 0.05% $185,578,979
Boston Partners 0.3% 3,676,899 -7.8% 0.18% $173,824,363
Mondrian Investment Partners LTD 0.3% 3,638,606 +5.7% 2.9% $171,742,203
RAYMOND JAMES FINANCIAL INC 0.28% 3,436,177 -42% 0.05% $162,187,479
ENVESTNET ASSET MANAGEMENT INC 0.28% 3,405,959 -0.85% 0.05% $160,761,251
ROYAL BANK OF CANADA 0.27% 3,276,254 +1.2% 0.03% $154,640,000
NATIXIS ADVISORS, LLC 0.25% 3,113,381 +12% 0.21% $146,952,000
Nuveen, LLC 0.25% 3,080,744 -0.52% 0.04% $145,411,116
FEDERATED HERMES, INC. 0.25% 3,035,254 -22% 0.25% $143,263,986
FMR LLC 0.24% 2,973,778 -17% 0.01% $140,362,338
WELLS FARGO & COMPANY/MN 0.23% 2,882,060 +3.3% 0.03% $136,033,219
BRANDES INVESTMENT PARTNERS, LP 0.23% 2,822,971 +14% 1.1% $133,245,051
JPMORGAN CHASE & CO 0.22% 2,655,394 +7% 0.01% $125,334,660
EQUITY INVESTMENT CORP 0.21% 2,587,690 +3% 2.6% $122,138,975
GOLDMAN SACHS GROUP INC 0.2% 2,479,328 -6.2% 0.02% $117,024,279
AMERICAN CENTURY COMPANIES INC 0.19% 2,338,969 +19% 0.06% $110,399,337

Institutional Holders of Sanofi - Common Stock and American Depositary Receipts (SNY) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (% of par) Investors
2025 Q4 519,964 $25,172,004 -$988,519 4,846% 37
2025 Q3 237,646,783 $11,217,952,523 -$540,304,609 4,720% 695
2025 Q2 244,532,481 $11,812,873,118 -$577,757,923 4,831% 717
2025 Q1 259,719,343 $14,402,699,131 -$180,272,150 5,546% 755
2024 Q4 264,041,146 $12,759,135,735 -$861,033,039 4,823% 709
2024 Q3 281,347,788 $16,217,574,700 +$599,802,411 5,763% 739
2024 Q2 271,041,181 $13,163,773,741 +$734,968,243 4,852% 708
2024 Q1 256,397,879 $12,459,545,280 +$385,486,107 4,860% 694
2023 Q4 159,830 $7,948,324 -$4,957,088 4,973% 6
2023 Q3 251,353,398 $13,476,886,797 -$165,306,955 5,364% 675
2023 Q2 253,726,198 $13,672,773,602 -$854,152,295 5,390% 654
2023 Q1 257,334,427 $14,002,947,082 +$261,210,757 5,442% 652
2022 Q4 260,482,164 $12,615,636,311 +$348,221,649 4,843% 617
2022 Q3 241,740,891 $9,197,380,535 +$22,972,972 3,802% 552
2022 Q2 257,888,447 $12,904,271,979 +$534,031,720 5,002.99% 627
2022 Q1 251,169,166 $12,889,539,401 +$356,108,026 5,133.96% 601
2021 Q4 243,898,352 $12,213,912,821 +$343,788,268 5,009.99% 602
2021 Q3 236,080,633 $11,376,647,775 +$1,639,829,613 4,820.97% 567
2021 Q2 202,091,169 $10,635,942,128 +$296,566,614 5,265.98% 571
2021 Q1 196,525,424 $9,720,089,027 +$1,144,591,303 4,945.99% 559
2020 Q4 174,536,810 $8,477,138,762 +$63,803,715 4,858.94% 586
2020 Q3 172,933,395 $8,668,417,417 -$298,524,748 5,017% 559
2020 Q2 178,670,688 $9,118,759,547 -$306,526,038 5,104.98% 567
2020 Q1 181,211,851 $7,922,145,322 +$321,072,044 4,372% 529
2019 Q4 179,139,108 $8,989,486,520 +$32,963,137 5,019.99% 511
2019 Q3 178,301,442 $8,257,684,178 +$171,230,297 4,632.97% 470
2019 Q2 174,592,460 $7,549,626,574 -$260,742,807 4,326.99% 466
2019 Q1 181,034,106 $8,015,991,957 +$105,616,985 4,427.87% 478
2018 Q4 178,698,479 $7,754,545,390 +$60,327,372 4,340.93% 491
2018 Q3 175,183,441 $7,822,348,995 -$494,462,781 4,466.93% 468
2018 Q2 188,692,277 $7,547,892,218 -$949,693,906 4,000.99% 467
2018 Q1 212,638,361 $8,519,248,248 -$561,808,249 4,007.96% 478
2017 Q4 225,475,494 $9,693,056,469 -$178,414,546 4,300% 491
2017 Q3 229,055,190 $11,401,200,286 -$309,036,172 4,979.01% 474
2017 Q2 235,249,910 $11,267,903,039 -$696,235,741 4,791% 468
2017 Q1 249,542,255 $11,288,726,978 +$48,474,507 4,525% 449
2016 Q4 249,782,549 $10,097,785,598 -$113,774,084 4,043.99% 468
2016 Q3 252,676,260 $9,649,495,037 +$366,749,063 3,819% 441
2016 Q2 242,095,337 $10,125,477,008 +$419,584,751 4,184.99% 443
2016 Q1 230,831,763 $9,323,966,705 +$92,629,761 4,015.97% 437
2015 Q4 227,864,620 $9,717,602,903 -$546,647,770 4,265% 471
2015 Q3 220,562,763 $10,470,143,607 -$443,333,648 4,746.99% 485
2015 Q2 250,373,124 $12,394,708,610 -$238,411,782 4,953% 489
2015 Q1 256,395,296 $12,675,717,814 +$433,034,362 4,944% 507
2014 Q4 249,297,200 $11,371,275,286 +$335,001,128 4,560.99% 490
2014 Q3 240,535,494 $13,574,315,282 +$165,900,403 5,642.98% 494
2014 Q2 237,674,962 $12,636,260,095 +$124,677,698 5,316.98% 482
2014 Q1 235,957,823 $12,335,851,355 +$594,761,547 5,228% 482